Phocas Financial Corp. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 1 filers reported holding ANI PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,367,000
+7.7%
75,213
-0.1%
0.64%
+14.4%
Q2 2023$4,053,000
+34.8%
75,285
-0.6%
0.56%
+28.8%
Q1 2023$3,007,000
-52.0%
75,704
-25.5%
0.43%
-42.8%
Q4 2019$6,263,000
-32.4%
101,567
-20.2%
0.75%
-23.8%
Q3 2019$9,270,000
-11.5%
127,200
-0.1%
0.99%
-11.8%
Q2 2019$10,472,000
+5.3%
127,391
-9.6%
1.12%
+12.0%
Q1 2019$9,945,000
+70.6%
140,977
+8.9%
1.00%
+53.8%
Q4 2018$5,829,000
+6.5%
129,476
+33.7%
0.65%
+35.4%
Q3 2018$5,473,000
+96.3%
96,805
+131.9%
0.48%
+100.0%
Q2 2018$2,788,00041,7410.24%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders